Market Value16,651,382,602
Total Holdings113
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NRIX / Nurix Therapeutics, Inc.
BHVN / Biohaven Ltd.
VERV / Verve Therapeutics, Inc.
INSM / Insmed Incorporated
RVMD / Revolution Medicines, Inc.
REPL / Replimune Group, Inc.
INCY / Incyte Corporation
KALA / KALA BIO, Inc.
AVTE / Aerovate Therapeutics, Inc.
KOD / Kodiak Sciences Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
SGEN / Seagen Inc
TSVT / 2seventy bio, Inc.
XENE / Xenon Pharmaceuticals Inc.
AGLE / Aeglea BioTherapeutics Inc
IPSC / Century Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
CABA / Cabaletta Bio, Inc.
TCRX / TScan Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
ATHA / Athira Pharma, Inc.
HOOK / HOOKIPA Pharma Inc.
RETA / Reata Pharmaceuticals Inc - Class A
PRAX / Praxis Precision Medicines, Inc.
TCRR / Tcr2 Therapeutics Inc
BCRX / BioCryst Pharmaceuticals, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
SMMT * / Summit Therapeutics Inc.
FHTX / Foghorn Therapeutics Inc.
BLUE / bluebird bio, Inc.
ZYME / Zymeworks Inc.
ABCL / AbCellera Biologics Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
ATRA / Atara Biotherapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
SWTX / SpringWorks Therapeutics, Inc.
PRLD / Prelude Therapeutics Incorporated
IMTX / Immatics N.V.
DSGN / Design Therapeutics, Inc.
ALKS / Alkermes plc
AADI / Aadi Bioscience, Inc.
CINC / CinCor Pharma Inc
FATE / Fate Therapeutics, Inc.
KDNY / Chinook Therapeutics Inc
ITOS / iTeos Therapeutics, Inc.
NKTX / Nkarta, Inc.
US457669AB50 / INSMED INC CONV 0.75% 06/01/2028
US46185LAB99 / Invitae Corp
KRON / Kronos Bio, Inc.
KZR / Kezar Life Sciences, Inc.
FMTX / Forma Therapeutics Holdings Inc
CCXI / ChemoCentryx Inc
SNDX / Syndax Pharmaceuticals, Inc.
FLGT / Fulgent Genetics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
TIL / Instil Bio, Inc.
RLMD / Relmada Therapeutics, Inc.
BCEL / Atreca, Inc.
ZYME / Zymeworks Inc.
HZNP / Horizon Therapeutics Plc
VINC / Vincerx Pharma, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
ALLK / Allakos Inc.
VERA / Vera Therapeutics, Inc.
LOGC / ContextLogic Holdings Inc.
CYTT / Cyteir Therapeutics, Inc.
GBT / Global Blood Therapeutics Inc.
SRZN / Surrozen, Inc.
ALT / Altimmune, Inc.
TCDA / Tricida Inc
OTIC / Otonomy Inc
VSTM / Verastem, Inc.
TVTX / Travere Therapeutics, Inc.
TRDA / Entrada Therapeutics, Inc.
FGEN / FibroGen, Inc.
VERU / Veru Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
LIFE / aTyr Pharma, Inc.
DICE / DICE Therapeutics Inc
RNA / Avidity Biosciences, Inc.
VOR / Vor Biopharma Inc.
CMPX / Compass Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
PMVP / PMV Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
TNGX / Tango Therapeutics, Inc.
PRME / Prime Medicine, Inc.
BMEA / Biomea Fusion, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
OPT / Opthea Limited - Depositary Receipt (Common Stock)
ALEC / Alector, Inc.
PCVX / Vaxcyte, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
LPTX / Leap Therapeutics, Inc.
AFMD / Affimed N.V.
PNT / POINT Biopharma Global Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
ROIV / Roivant Sciences Ltd.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
IGMS / IGM Biosciences, Inc.
SERA / Sera Prognostics, Inc.
AKRO / Akero Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
CERS / Cerus Corporation
STOK / Stoke Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
RARE / Ultragenyx Pharmaceutical Inc.
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
CBAY / CymaBay Therapeutics, Inc.
ANAB / AnaptysBio, Inc.
ALGS / Aligos Therapeutics, Inc.
TLIS / Talis Biomedical Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
MRTX / Mirati Therapeutics, Inc.
MGNX / MacroGenics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
SPRY / ARS Pharmaceuticals, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ARAV / Aravive, Inc.
NVTA / Invitae Corporation
PACB / Pacific Biosciences of California, Inc.
NTRA / Natera, Inc.
DNLI / Denali Therapeutics Inc.
HRTX / Heron Therapeutics, Inc.